<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>19232222</identifier>
<setSpec>1130-6343</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>del Pozo Ruiz, J J</dc:author>
<dc:author>Rodríguez Lage, C</dc:author>
<dc:author>Ramos Ortega, F</dc:author>
<dc:author>Ortega Valín, L</dc:author>
<dc:type>Letter</dc:type>
<dc:language>es</dc:language>
<dc:date>2008 Nov-Dec </dc:date>
<dc:title xml:lang="es">Lenalidomida: efectos adversos y comercialización.</dc:title>
<dc:title xml:lang="en">[Lenalidomide; adverse effects and commercialisation].</dc:title>
<dc:publisher>Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria</dc:publisher>
</metadata>
</record>
</pubmed-document>
